UpCard

RSS

Torasemide

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for UpCard. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use UpCard.

For practical information about using UpCard, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 29/09/2020

Authorisation details

Product details
Name
UpCard
Agency product number
EMEA/V/C/003836
Active substance
Torasemide anhydrous
International non-proprietary name (INN) or common name
Torasemide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QC03CA04
Publication details
Marketing-authorisation holder
Vétoquinol SA
Revision
2
Date of issue of marketing authorisation valid throughout the European Union
31/07/2015
Contact address
Magny-Vernois
F-70 200 Lure
France

Product information

24/06/2020 UpCard - EMEA/V/C/003836 - II/0005/G

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Sulfonamides, plain
  • High-ceiling diuretics

Therapeutic indication

For treatment of clinical signs, including oedema and effusion, related to congestive heart failure in dogs.

Assessment history

How useful was this page?

Add your rating
Average
1 rating